Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding*

P-glycoprotein is an ATP-binding cassette transporter that is associated with multidrug resistance and the failure of chemotherapy in human patients. We have previously shown, based on two-dimensional projection maps, that P-glycoprotein undergoes conformational changes upon binding of nucleotide to the intracellular nucleotide binding domains. Here we present the three-dimensional structures of P-glycoprotein in the presence and absence of nucleotide, at a resolution limit of ∼2 nm, determined by electron crystallography of negatively stained crystals. The data reveal a major reorganization of the transmembrane domains throughout the entire depth of the membrane upon binding of nucleotide. In the absence of nucleotide, the two transmembrane domains form a single barrel 5–6 nm in diameter and about 5 nm deep with a central pore that is open to the extracellular surface and spans much of the membrane depth. Upon binding nucleotide, the transmembrane domains reorganize into three compact domains that are each 2–3 nm in diameter and 5–6 nm deep. This reorganization opens the central pore along its length in a manner that could allow access of hydrophobic drugs (transport substrates) directly from the lipid bilayer to the central pore of the transporter.

[1]  A. E. Senior,et al.  Projection Structure of P-glycoprotein by Electron Microscopy , 2002, The Journal of Biological Chemistry.

[2]  S. Ruffle,et al.  The Location of Plastocyanin in Vascular Plant Photosystem I* , 2002, The Journal of Biological Chemistry.

[3]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[4]  I. Kerr Structure and association of ATP-binding cassette transporter nucleotide-binding domains. , 2002, Biochimica et biophysica acta.

[5]  C. Higgins,et al.  The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein. , 2001, Biochemistry.

[6]  K. Linton,et al.  Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.

[7]  C. B. Roth,et al.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. , 2001, Science.

[8]  Rachelle Gaudet,et al.  Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing , 2001, The EMBO journal.

[9]  I. Roninson,et al.  Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein. , 2001, Biochemistry.

[10]  I. Roninson,et al.  Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity. , 2001, Biochemistry.

[11]  K. Diederichs,et al.  Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis , 2000, The EMBO journal.

[12]  F. Sharom,et al.  Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. , 2000, Biochemistry.

[13]  C. Higgins,et al.  Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis. , 2000, Biochemistry.

[14]  John A. Tainer,et al.  Structural Biology of Rad50 ATPase ATP-Driven Conformational Control in DNA Double-Strand Break Repair and the ABC-ATPase Superfamily , 2000, Cell.

[15]  P. Gros,et al.  Nucleotide-induced conformational changes in P-glycoprotein and in nucleotide binding site mutants monitored by trypsin sensitivity. , 2000, Biochemistry.

[16]  Z. Sauna,et al.  Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Higgins,et al.  The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein , 1999, British journal of pharmacology.

[18]  C. Vigano,et al.  Ligand-mediated Tertiary Structure Changes of Reconstituted P-glycoprotein , 1999, The Journal of Biological Chemistry.

[19]  W. Kühlbrandt,et al.  Surface crystallisation of the plasma membrane H+-ATPase on a carbon support film for electron crystallography. , 1999, Journal of molecular biology.

[20]  Li-Wei Hung,et al.  Crystal structure of the ATP-binding subunit of an ABC transporter , 1998, Nature.

[21]  W. Kühlbrandt,et al.  Three-dimensional map of the plasma membrane H+-ATPase in the open conformation , 1998, Nature.

[22]  K. Linton,et al.  The Escherichia coli ATP‐binding cassette (ABC) proteins , 1998, Molecular microbiology.

[23]  R. Pincheira,et al.  Conformational changes of P-glycoprotein by nucleotide binding. , 1997, The Biochemical journal.

[24]  C. Higgins,et al.  The multi‐drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P‐glycoprotein by an allosteric interaction , 1997, British journal of pharmacology.

[25]  C. Higgins,et al.  The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. , 1997, Biochimica et biophysica acta.

[26]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[27]  D. Clarke,et al.  Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332 in Predicted Transmembrane Segments (TM) 6 and 975 in Predicted TM12 of Human P-glycoprotein by Drug Substrates* , 1996, The Journal of Biological Chemistry.

[28]  E. Goormaghtigh,et al.  Secondary and Tertiary Structure Changes of Reconstituted P-glycoprotein , 1996, The Journal of Biological Chemistry.

[29]  F. Sharom,et al.  Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. , 1996, Biochemistry.

[30]  B. Sankaran,et al.  P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*) , 1995, The Journal of Biological Chemistry.

[31]  J. Harris,et al.  Human erythrocyte catalase: 2-D crystal nucleation and production of multiple crystal forms. , 1995, Journal of structural biology.

[32]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[33]  B. Sarkadi,et al.  Calcein accumulation as a fluorometric functional assay of the multidrug transporter. , 1994, Biochimica et biophysica acta.

[34]  A. E. Senior,et al.  Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. , 1993, The Journal of biological chemistry.

[35]  K. Downing,et al.  Assessment of resolution in biological electron crystallography. , 1992, Ultramicroscopy.

[36]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[37]  D. McRee,et al.  A visual protein crystallographic software system for X11/Xview , 1992 .

[38]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[39]  David R. Brillinger,et al.  Some statistical aspects of low-dose electron imaging of crystals , 1990 .

[40]  I. Pastan,et al.  Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.

[41]  I. J. Evans,et al.  A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria , 1986, Nature.

[42]  R A Crowther,et al.  MRC image processing programs. , 1996, Journal of structural biology.

[43]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[44]  R. Henderson,et al.  Three-dimensional structure determination by electron microscopy of two-dimensional crystals. , 1982, Progress in biophysics and molecular biology.